https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Minimal disease activity for rheumatoid arthritis: a preliminary definition https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:604 Thu 25 Jul 2013 09:10:23 AEST ]]> Standardized assessment of adverse events in rheumatology clinical trials: Summary of the OMERACT 7 Drug Safety Module update https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:315 Sat 24 Mar 2018 07:42:42 AEDT ]]> Generic patient self-report and investigator report instruments of therapeutic safety and tolerability https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:359 Sat 24 Mar 2018 07:42:36 AEDT ]]> Challenges and progress in adverse event ascertainment and reporting in clinical trials https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:340 Sat 24 Mar 2018 07:42:26 AEDT ]]>